The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kusmartsev, S. A.
Right arrow Articles by Chen, S.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kusmartsev, S. A.
Right arrow Articles by Chen, S.-H.
The Journal of Immunology, 00, 165: 779-785.
Copyright © 00 by The American Association of Immunologists

Gr-1+ Myeloid Cells Derived from Tumor-Bearing Mice Inhibit Primary T Cell Activation Induced Through CD3/CD28 Costimulation1

Sergei A. Kusmartsev, Yu Li and Shu-Hsia Chen2

Institute for Gene Therapy and Molecular Medicine, Mount Sinai School of Medicine, New York, NY 10029

Activation of T cells is a necessary step in the development of a specific antitumor immune response. In the present study, we evaluated the ability of Gr-1+ myeloid cells, derived from the bone marrow or spleen of tumor-bearing mice, to inhibit CD3/CD28-mediated T cell activation. Using flow cytometry, we found that growth of a murine colon carcinoma (MCA-26) induces a significant increase in the number of Gr-1+ and Gr-1+/Mac-1+ myeloid cells in both bone marrow and spleen of the tumor host. The proliferative response of T cells was dramatically decreased when naive T cells were activated by anti-CD3 and anti-CD28 Abs in the presence of a myeloid-enriched cell fraction derived from spleen or bone marrow of tumor-bearing mice vs the bone marrow of naive mice. Reversal of the inhibitory effect could be achieved by adding a combination of MnTBAP (manganese [III] tetrakis [4-benzoic acid]) porphyrin and L-NMMA (NG-monomethyl-L-arginine), a superoxide dismutase mimetic and inducible NO synthase inhibitor, respectively, or by depletion of the Gr-1-positive cells. IFN-{gamma}, which is endogenously produced by CD3/CD28-stimulated naive T cells, is involved in induction of the inhibitory activity of myeloid cells. Importantly, when T cells pre-activated with anti-CD3 Abs were used as responder cells, the bone marrow- or spleen-derived Gr-1+ myeloid cells were unable to suppress CD3/CD28-induced T cell proliferation. Our findings suggest that one mechanism by which an increased number of immune suppressive Gr-1+ cells can induce T cell unresponsiveness or immune tolerance in tumor hosts could be through peroxynitrite production upon primary T cell activation.




This article has been cited by other articles:


Home page
 J. Leukoc. Biol.Home page
F. Pages, J. Galon, and W. H. Fridman
The essential role of the in situ immune reaction in human colorectal cancer
J. Leukoc. Biol., October 1, 2008; 84(4): 981 - 987.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Watanabe, K. Deguchi, R. Zheng, H. Tamai, L.-x. Wang, P. A. Cohen, and S. Shu
Tumor-Induced CD11b+Gr-1+ Myeloid Cells Suppress T Cell Sensitization in Tumor-Draining Lymph Nodes
J. Immunol., September 1, 2008; 181(5): 3291 - 3300.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. J. Gough, C. E. Ruby, W. L. Redmond, B. Dhungel, A. Brown, and A. D. Weinberg
OX40 Agonist Therapy Enhances CD8 Infiltration and Decreases Immune Suppression in the Tumor
Cancer Res., July 1, 2008; 68(13): 5206 - 5215.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Kusmartsev, E. Eruslanov, H. Kubler, T. Tseng, Y. Sakai, Z. Su, S. Kaliberov, A. Heiser, C. Rosser, P. Dahm, et al.
Oxidative Stress Regulates Expression of VEGFR1 in Myeloid Cells: Link to Tumor-Induced Immune Suppression in Renal Cell Carcinoma
J. Immunol., July 1, 2008; 181(1): 346 - 353.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A.-S. Dugast, T. Haudebourg, F. Coulon, M. Heslan, F. Haspot, N. Poirier, R. Vuillefroy de Silly, C. Usal, H. Smit, B. Martinet, et al.
Myeloid-Derived Suppressor Cells Accumulate in Kidney Allograft Tolerance and Specifically Suppress Effector T Cell Expansion
J. Immunol., June 15, 2008; 180(12): 7898 - 7906.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Y. Sawanobori, S. Ueha, M. Kurachi, T. Shimaoka, J. E. Talmadge, J. Abe, Y. Shono, M. Kitabatake, K. Kakimi, N. Mukaida, et al.
Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice
Blood, June 15, 2008; 111(12): 5457 - 5466.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
P.-Y. Pan, G. X. Wang, B. Yin, J. Ozao, T. Ku, C. M. Divino, and S.-H. Chen
Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function
Blood, January 1, 2008; 111(1): 219 - 228.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. Zhu, Y. Bando, S. Xiao, K. Yang, A. C. Anderson, V. K. Kuchroo, and S. J. Khoury
CD11b+Ly-6Chi Suppressive Monocytes in Experimental Autoimmune Encephalomyelitis
J. Immunol., October 15, 2007; 179(8): 5228 - 5237.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. E. Clark, S. R. Hingorani, R. Mick, C. Combs, D. A. Tuveson, and R. H. Vonderheide
Dynamics of the Immune Reaction to Pancreatic Cancer from Inception to Invasion
Cancer Res., October 1, 2007; 67(19): 9518 - 9527.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. J. Stewart and S. I. Abrams
Altered Immune Function during Long-Term Host-Tumor Interactions Can Be Modulated to Retard Autochthonous Neoplastic Growth
J. Immunol., September 1, 2007; 179(5): 2851 - 2859.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Sinha, V. K. Clements, S. K. Bunt, S. M. Albelda, and S. Ostrand-Rosenberg
Cross-Talk between Myeloid-Derived Suppressor Cells and Macrophages Subverts Tumor Immunity toward a Type 2 Response
J. Immunol., July 15, 2007; 179(2): 977 - 983.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Y. Huang, X. Chen, M. M. Dikov, S. V. Novitskiy, C. A. Mosse, L. Yang, and D. P. Carbone
Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF
Blood, July 15, 2007; 110(2): 624 - 631.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. Sinha, V. K. Clements, A. M. Fulton, and S. Ostrand-Rosenberg
Prostaglandin E2 Promotes Tumor Progression by Inducing Myeloid-Derived Suppressor Cells
Cancer Res., May 1, 2007; 67(9): 4507 - 4513.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Vieweg, Z. Su, P. Dahm, and S. Kusmartsev
Reversal of Tumor-Mediated Immunosuppression
Clin. Cancer Res., January 15, 2007; 13(2): 727s - 732s.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Minguela, S. Pastor, W. Mi, J. A. Richardson, and E. S. Ward
Feedback Regulation of Murine Autoimmunity via Dominant Anti-Inflammatory Effects of Interferon {gamma}
J. Immunol., January 1, 2007; 178(1): 134 - 144.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. V. Ezernitchi, I. Vaknin, L. Cohen-Daniel, O. Levy, E. Manaster, A. Halabi, E. Pikarsky, L. Shapira, and M. Baniyash
TCR {zeta} Down-Regulation under Chronic Inflammation Is Mediated by Myeloid Suppressor Cells Differentially Distributed between Various Lymphatic Organs
J. Immunol., October 1, 2006; 177(7): 4763 - 4772.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. Mirza, M. Fishman, I. Fricke, M. Dunn, A. M. Neuger, T. J. Frost, R. M. Lush, S. Antonia, and D. I. Gabrilovich
All-trans-Retinoic Acid Improves Differentiation of Myeloid Cells and Immune Response in Cancer Patients.
Cancer Res., September 15, 2006; 66(18): 9299 - 9307.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
I. Kryczek, L. Zou, P. Rodriguez, G. Zhu, S. Wei, P. Mottram, M. Brumlik, P. Cheng, T. Curiel, L. Myers, et al.
B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma
J. Exp. Med., April 17, 2006; 203(4): 871 - 881.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. Huang, P.-Y. Pan, Q. Li, A. I. Sato, D. E. Levy, J. Bromberg, C. M. Divino, and S.-H. Chen
Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host
Cancer Res., January 15, 2006; 66(2): 1123 - 1131.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. K. Bunt, P. Sinha, V. K. Clements, J. Leips, and S. Ostrand-Rosenberg
Inflammation Induces Myeloid-Derived Suppressor Cells that Facilitate Tumor Progression
J. Immunol., January 1, 2006; 176(1): 284 - 290.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Fujigaki, K. Saito, F. Lin, S. Fujigaki, K. Takahashi, B. M. Martin, C. Y. Chen, J. Masuda, J. Kowalak, O. Takikawa, et al.
Nitration and Inactivation of IDO by Peroxynitrite
J. Immunol., January 1, 2006; 176(1): 372 - 379.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Kusmartsev, S. Nagaraj, and D. I. Gabrilovich
Tumor-Associated CD8+ T Cell Tolerance Induced by Bone Marrow-Derived Immature Myeloid Cells
J. Immunol., October 1, 2005; 175(7): 4583 - 4592.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. Larrivee, I. Pollet, and A. Karsan
Activation of Vascular Endothelial Growth Factor Receptor-2 in Bone Marrow Leads to Accumulation of Myeloid Cells: Role of Granulocyte-Macrophage Colony-Stimulating Factor
J. Immunol., September 1, 2005; 175(5): 3015 - 3024.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Honeychurch, M. J. Glennie, and T. M. Illidge
Cyclophosphamide Inhibition of Anti-CD40 Monoclonal Antibody-Based Therapy of B Cell Lymphoma Is Dependent on CD11b+ Cells
Cancer Res., August 15, 2005; 65(16): 7493 - 7501.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. P. Zehntner, C. Brickman, L. Bourbonniere, L. Remington, M. Caruso, and T. Owens
Neutrophils That Infiltrate the Central Nervous System Regulate T Cell Responses
J. Immunol., April 15, 2005; 174(8): 5124 - 5131.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M.-B. Voisin, D. Buzoni-Gatel, D. Bout, and F. Velge-Roussel
Both Expansion of Regulatory GR1+ CD11b+ Myeloid Cells and Anergy of T Lymphocytes Participate in Hyporesponsiveness of the Lung-Associated Immune System during Acute Toxoplasmosis
Infect. Immun., September 1, 2004; 72(9): 5487 - 5492.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
M. J. Skeen, M. M. Freeman, and H. K. Ziegler
Changes in peritoneal myeloid populations and their proinflammatory cytokine expression during infection with Listeria monocytogenes are altered in the absence of {gamma}/{delta} T cells
J. Leukoc. Biol., July 1, 2004; 76(1): 104 - 115.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Q. Li, P.-Y. Pan, P. Gu, D. Xu, and S.-H. Chen
Role of Immature Myeloid Gr-1+ Cells in the Development of Antitumor Immunity
Cancer Res., February 1, 2004; 64(3): 1130 - 1139.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Kusmartsev, Y. Nefedova, D. Yoder, and D. I. Gabrilovich
Antigen-Specific Inhibition of CD8+ T Cell Response by Immature Myeloid Cells in Cancer Is Mediated by Reactive Oxygen Species
J. Immunol., January 15, 2004; 172(2): 989 - 999.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. A. Perry, A. Rush, R. J. Wilson, C. S. Olver, and A. C. Avery
Dendritic Cells from Malaria-Infected Mice Are Fully Functional APC
J. Immunol., January 1, 2004; 172(1): 475 - 482.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
M. Terabe, S. Matsui, J.-M. Park, M. Mamura, N. Noben-Trauth, D. D. Donaldson, W. Chen, S. M. Wahl, S. Ledbetter, B. Pratt, et al.
Transforming Growth Factor-{beta} Production and Myeloid Cells Are an Effector Mechanism through Which CD1d-restricted T Cells Block Cytotoxic T Lymphocyte-mediated Tumor Immunosurveillance: Abrogation Prevents Tumor Recurrence
J. Exp. Med., December 1, 2003; 198(11): 1741 - 1752.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. Melani, C. Chiodoni, G. Forni, and M. P. Colombo
Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity
Blood, September 15, 2003; 102(6): 2138 - 2145.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Kusmartsev, F. Cheng, B. Yu, Y. Nefedova, E. Sotomayor, R. Lush, and D. Gabrilovich
All-trans-Retinoic Acid Eliminates Immature Myeloid Cells from Tumor-bearing Mice and Improves the Effect of Vaccination
Cancer Res., August 1, 2003; 63(15): 4441 - 4449.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
S. Kusmartsev and D. I. Gabrilovich
Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species
J. Leukoc. Biol., August 1, 2003; 74(2): 186 - 196.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Dupuis, M. de Jesus Ibarra-Sanchez, M. L. Tremblay, and P. Duplay
Gr-1+ Myeloid Cells Lacking T Cell Protein Tyrosine Phosphatase Inhibit Lymphocyte Proliferation by an IFN-{gamma}- and Nitric Oxide-Dependent Mechanism
J. Immunol., July 15, 2003; 171(2): 726 - 732.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Liu, J. A. Van Ginderachter, L. Brys, P. De Baetselier, G. Raes, and A. B. Geldhof
Nitric Oxide-Independent CTL Suppression during Tumor Progression: Association with Arginase-Producing (M2) Myeloid Cells
J. Immunol., May 15, 2003; 170(10): 5064 - 5074.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
V. Bronte, P. Serafini, C. De Santo, I. Marigo, V. Tosello, A. Mazzoni, D. M. Segal, C. Staib, M. Lowel, G. Sutter, et al.
IL-4-Induced Arginase 1 Suppresses Alloreactive T Cells in Tumor-Bearing Mice
J. Immunol., January 1, 2003; 170(1): 270 - 278.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. B. Geldhof, J. A. Van Ginderachter, Y. Liu, W. Noel, G. Raes, and P. De Baetselier
Antagonistic effect of NK cells on alternatively activated monocytes: a contribution of NK cells to CTL generation
Blood, December 1, 2002; 100(12): 4049 - 4058.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
O. Goni, P. Alcaide, and M. Fresno
Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G (Gr1+)CD11b+ immature myeloid suppressor cells
Int. Immunol., October 1, 2002; 14(10): 1125 - 1134.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Mencacci, C. Montagnoli, A. Bacci, E. Cenci, L. Pitzurra, A. Spreca, M. Kopf, A. H. Sharpe, and L. Romani
CD80+Gr-1+ Myeloid Cells Inhibit Development of Antifungal Th1 Immunity in Mice with Candidiasis
J. Immunol., September 15, 2002; 169(6): 3180 - 3190.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Mazzoni, V. Bronte, A. Visintin, J. H. Spitzer, E. Apolloni, P. Serafini, P. Zanovello, and D. M. Segal
Myeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism
J. Immunol., January 15, 2002; 168(2): 689 - 695.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
E. A. Patton, A. C. La Flamme, J. A. Pedras-Vasoncelos, and E. J. Pearce
Central Role for Interleukin-4 in Regulating Nitric Oxide-Mediated Inhibition of T-Cell Proliferation and Gamma Interferon Production in Schistosomiasis
Infect. Immun., January 1, 2002; 70(1): 177 - 184.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. I. Terrazas, K. L. Walsh, D. Piskorska, E. McGuire, and D. A. Harn Jr.
The Schistosome Oligosaccharide Lacto-N-neotetraose Expands Gr1+ Cells That Secrete Anti-inflammatory Cytokines and Inhibit Proliferation of Naive CD4+ Cells: A Potential Mechanism for Immune Polarization in Helminth Infections
J. Immunol., November 1, 2001; 167(9): 5294 - 5303.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
O. Atochina, T. Daly-Engel, D. Piskorska, E. McGuire, and D. A. Harn
A Schistosome-Expressed Immunomodulatory Glycoconjugate Expands Peritoneal Gr1+ Macrophages That Suppress Naive CD4+ T Cell Proliferation Via an IFN-{gamma} and Nitric Oxide-Dependent Mechanism
J. Immunol., October 15, 2001; 167(8): 4293 - 4302.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. J. Dobrzanski, J. B. Reome, and R. W. Dutton
Role of Effector Cell-Derived IL-4, IL-5, and Perforin in Early and Late Stages of Type 2 CD8 Effector Cell-Mediated Tumor Rejection
J. Immunol., July 1, 2001; 167(1): 424 - 434.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. Y. Woo, C. S. Chu, T. J. Goletz, K. Schlienger, H. Yeh, G. Coukos, S. C. Rubin, L. R. Kaiser, and C. H. June
Regulatory CD4+CD25+ T Cells in Tumors from Patients with Early-Stage Non-Small Cell Lung Cancer and Late-Stage Ovarian Cancer
Cancer Res., June 1, 2001; 61(12): 4766 - 4772.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. Pelaez, J. A. Campillo, J. A. Lopez-Asenjo, and J. L. Subiza
Cyclophosphamide Induces the Development of Early Myeloid Cells Suppressing Tumor Cell Growth by a Nitric Oxide-Dependent Mechanism
J. Immunol., June 1, 2001; 166(11): 6608 - 6615.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. I. Gabrilovich, M. P. Velders, E. M. Sotomayor, and W. M. Kast
Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells
J. Immunol., May 1, 2001; 166(9): 5398 - 5406.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.